Sedation: Clinical Trials

28 trials for Sedation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 2 suspended, 2 unknown, 1 active not recruiting. 28 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 328Completed 21, Suspended 2, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 25Completed 3, Suspended 2

Follow Sedation: new trials by email Literature Review of Sedation trials Research Report on Sedation

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
Remimazolam, Propofol - Anesthesia, Sedation
Phase 3CompletedMassachusetts General Hospital1002026-03-032026-09-14
Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU
Remimazolam, propofol - Remimazolam Besylate, Mechanically Ventilated ICU Patients
Phase 3RecruitingSoutheast University, China802025-04-012026-05-19
The Effect of Music on the Sedation Quality Among Children in the Emergency Department.
Music intervention - Sedation
Phase 3CompletedTehran University of Medical Sciences882025-03-312025-12-08
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
Isoflurane, Propofol - Sedation
Phase 3CompletedSedana Medical2822022-06-302026-03-24
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
Isoflurane, Propofol, Isoflurane (run-ins) - Sedation
Phase 3CompletedSedana Medical2772022-04-282026-03-24
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
Inhaled isoflurane administered by Sedaconda ACD-S, Intravenous infusion of propofol - Post-Intensive Care Syndrome, Sedation
Phase 3Active not recruitingSedana Medical3122022-04-222025-02-05
Adjuvant Continuous Infusion of Nefopam Versus Standard of Care in Mechanically Ventilated Critically Ill Patients: Randomized Double-blind Controlled Study
Nefopam, Standard of care in the ICU for assessment and management of pain, sedation, and delirium. - Analgesia, Critical Illness
Phase 3CompletedCairo University602021-10-012025-12-19
Risk Prediction of Dexmedetomidine-associated Hemodynamic Instability
DEX 0.2 μg/kg/h. - Sedation
Phase 2 / Phase 3SuspendedAssiut University2502021-06-012021-01-14
Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old
Midazolam, Isoflurane - Sedation
Phase 3CompletedSedana Medical942021-01-142025-05-25
Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation
Propranolol Hydrochloride - Mechanical Ventilation, Sedation
Phase 3CompletedOttawa Hospital Research Institute722021-01-082022-12-05
A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy
Remimazolam Tosilate, Propofol - Sedation
Phase 3CompletedJiangsu HengRui Medicine Co., Ltd.3302020-06-152022-08-22
The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation
Dexmedetomidine, Ketamine - ICU Patients, Sedation
Phase 3UnknownLebanese American University Medical Center3942019-09-162020-02-20
Analgosedative adjuncT keTAmine Infusion iN Mechanically vENTilated ICU Patients
Ketamine - Critical Illness, Sedation
Phase 3CompletedKing Faisal Specialist Hospital & Research Center842019-08-282021-05-07
Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care
Opioids, Dexmedetomidine, Placebo - Analgesia, Sedation
Phase 3TerminatedWalid HABRE332018-11-142021-07-28
Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy
Remimazolam Tosilate, Propofol - Sedation
Phase 3CompletedJiangsu HengRui Medicine Co., Ltd.3882018-06-282018-12-19
Sedation MRI - Propofol Versus Propofol-Ketamin in Children
Propofol, Ketamine-Propofol - Sedation
Phase 3CompletedAchim Schmitz3472018-02-092024-12-20
Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients
0.2-0.7 mcg/kg/h dexmedetomedine infusion., 10-70 mcg/kg/h propofol infusion. - Sedation
Phase 2 / Phase 3SuspendedAssiut University602017-09-142020-07-14
Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy
Remimazolam Tosilate, Propofol - Sedation
Phase 3CompletedJiangsu HengRui Medicine Co., Ltd.3782017-09-012018-02-12
Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine.
OTM Dexmedetomidine 1µg/ kg., OTM Dexmedetomidine 0.75µg/ kg., OTM Dexmedetomidine 0.5µg/ kg. - Sedation
Phase 2 / Phase 3CompletedAssiut University362017-04-052019-08-01
Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure
Dexmedetomidine 0.35µg/kg /h, Dexmedetomidine 0.5µg/kg /h - Sedation
Phase 2 / Phase 3CompletedAssiut University402016-12-012018-07-03

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Critical Illness (3)  ·  Agnosia (2)  ·  Delirium (2)  ·  Epilepsy (1)  ·  Motor Activity (1)  ·  Pain (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  postintensive care syndrome (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (5)  ·  Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Signs and Symptoms (4)  ·  Disease Attributes (3)  ·  Mental Disorders (3)  ·  Neurobehavioral Manifestations (3)  ·  Pathologic Processes (3)  ·  Confusion (2)  ·  Neurocognitive Disorders (2)  ·  Perceptual Disorders (2)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Stress Disorders, Traumatic (1)

Interventions

Dexmedetomidine (11)  ·  Propofol (8)  ·  Midazolam (4)  ·  Isoflurane (3)  ·  Fentanyl (2)  ·  Ketamine (2)  ·  Morphine (2)  ·  remimazolam (2)  ·  Analgesics, Opioid (1)  ·  Chloral Hydrate (1)  ·  Melatonin (1)  ·  Nefopam (1)  ·  Propranolol (1)  ·  Restraint, Physical (1)  ·  Saline Solution (1)

Sponsors

Assiut University (4)  ·  Hospira, now a wholly owned subsidiary of Pfizer (4)  ·  Sedana Medical (4)  ·  Jiangsu HengRui Medicine Co., Ltd. (3)  ·  Achim Schmitz (1)  ·  Cairo University (1)  ·  King Faisal Specialist Hospital & Research Center (1)  ·  Lebanese American University Medical Center (1)  ·  Massachusetts General Hospital (1)  ·  Ottawa Hospital Research Institute (1)  ·  Pfizer (1)  ·  Southeast University, China (1)  ·  Tehran University of Medical Sciences (1)  ·  The University of Hong Kong (1)  ·  Ullevaal University Hospital (1)

Countries

United States (6)  ·  Egypt (5)  ·  China (4)  ·  Japan (3)  ·  Canada (2)  ·  Switzerland (2)  ·  France (1)  ·  Germany (1)  ·  Guatemala (1)  ·  Hong Kong (1)  ·  Iran (1)  ·  Lebanon (1)  ·  Norway (1)  ·  Saudi Arabia (1)  ·  South Africa (1)

Top investigators

Hala S Abdelghaffar, MD (2)  ·  Peter Sackey, MD, PhD (2)  ·  Achim J Schmitz, MD (1)  ·  Hadi Mirfazaelian, MD (1)  ·  Hala S Abdel-Ghaffar, MD (1)  ·  James Downar, MDCM (1)  ·  Jeremy Beitler, M.D. (1)  ·  Kimberly Rengel, M.D. (1)  ·  Misa Kawai (1)  ·  Mohammed Gamal Abdelraouf Amer, Pharm D (1)  ·  Oluwaseun Johnson-Akeju, MD (1)  ·  Robert Bilkovski, MD (1)  ·  Saher A Mohamed, MD (1)

Results publications

PMID 24238862, PMID 32197636, PMID 32889844, PMID 34462007, PMID 35221757, PMID 35221758, PMID 37170043, PMID 38767196, PMID 39461861, PMID 39982178, PMID 40165305, PMID 40250620, PMID 40680761